Finding the optimal regimen for short-term daily recombinant human erythropoietin treatment for blood-saving purpose in patients undergoing unilateral primary total hip arthroplasty: a double-blinded randomized placebo-controlled trial.

Yuan, Mingcheng; Tao, Qifeng; Wang, Duan; Wang, Haoyang; Zhou, Zongke

Yuan, Mingcheng; Tao, Qifeng; Wang, Duan; Wang, Haoyang; Zhou, Zongke.

Afiliação

Yuan M; Department of Orthopedics, West China Hospital/West China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, People's Republic of China.
Tao Q; Department of Orthopedics, Panzhihua Municipal Central Hospital Panzhihua, Panzhihua, People's Republic of China.
Wang D; Department of Orthopedics, West China Hospital/West China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, People's Republic of China.
Wang H; Department of Orthopedics, West China Hospital/West China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, People's Republic of China.
Zhou Z; Department of Orthopedics, West China Hospital/West China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road, Chengdu, People's Republic of China. zongkehx@126.com.

BMC Musculoskelet Disord ; 23(1): 243, 2022 Mar 12.

Article em En | MEDLINE | ID: mdl-35279105

Assuntos

Artroplastia de Quadril; Eritropoetina; Recuperação de Sangue Operatório; Artroplastia de Quadril/efeitos adversos; Protocolos Clínicos; Humanos; Proteínas Recombinantes/uso terapêutico

Palavras-chave

Blood-saving; Optimal regimen; Recombinant human erythropoietin; Total hip arthroplasty

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eritropoetina / Artroplastia de Quadril / Recuperação de Sangue Operatório Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google